Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AquaVita NextGen vs myRocky

AquaVita NextGen
Graded #415

Higher grade

vs+4.899999999999999
myRocky
Graded #487

Lower grade

The verdict

AquaVita NextGen takes it — 56.3/100 to 51.4/100.

AquaVita NextGen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AquaVita NextGen (AquaVita Wellness & Medspa) offers compounded semaglutide and tirzepatide (ODT tablets).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuemyRocky +11
23
34
Dose & formulationAquaVita NextGen +22
75
53
Clinical oversightAquaVita NextGen +18
82
64
Labs & monitoringAquaVita NextGen +1
53
52
FulfillmentmyRocky +8
62
70
Contract termsAquaVita NextGen +6
47
41
AquaVita NextGen · left barmyRocky · right bar

The numbers

MetricAquaVita NextGenmyRocky
WeighScore56.3/10051.4/100
GradeCC
Scorecard rank#415#487
Semaglutide$375/mo (first-month rate, compounded)Not disclosed
Tirzepatide$320/mo (starting dose, 3-month plan, compounded)Not disclosed
Coverage5 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
AquaVita NextGen

Graded #415 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard